Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on June 12, 2007
JNCI Journal of the National Cancer Institute 2007 99(12):973; doi:10.1093/jnci/djm001
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/12/973    most recent
djm001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Go, R. S.
Right arrow Articles by Frisby, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Go, R. S.
Right arrow Articles by Frisby, K. A.
Related Collections
Right arrowRelated Article in JNCI
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Re: Has Demand for Clinical Trial Participants Outpaced Supply?

Ronald S. Go, Lori A. Meyer, Kathleen A. Frisby

Affiliations of authors: Center for Cancer and Blood Disorders, Gundersen Lutheran Health System, La Crosse, WI

Correspondence to: Ronald S. Go, MD, Center for Cancer and Blood Disorders, Gundersen Lutheran Health System, Mail Stop: EB02-001, 1900 South Ave, La Crosse, WI 54601 (e-mail: rsgo@gundluth.org).

The first 10% of the full text of this article appears below.

Tam-McDevitt et al. (1) recently queried the National Institutes of Health Web site for all open US trials of breast, lung, or prostate cancers. They excluded trials that involved more than one type of cancer and counted 50% of the accrual goal for trials that also recruited participants from other countries. They found that the number of participants needed . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article in JNCI

Has Demand for Clinical Trial Participants Outpaced Supply?
Jennifer T. Tam-McDevitt, Lodovico Balducci, Robert S. Hauser, Daniel Gura, Aram Paraghamian, Heidi Thomas, and Stuart M. Lichtman
J Natl Cancer Inst 2007 99: 86-87. [Extract] [Full Text] [PDF]

Response to this Correspondence

Response: Re: Has Demand for Clinical Trial Participants Outpaced Supply?
Jennifer Tam-McDevitt, Lodovico Balducci, Robert Hauser, and Stuart Lichtman
J Natl Cancer Inst 2007 99: 973-974. [Extract] [Full Text] [PDF]